Guj. Themis Bio.

50
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
369.40
12.9 (3.62%)
BSENSE

Aug 10, 03:20 PM

BSE+NSE Vol: 1.2 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024

Compare Profit and Loss Results of Guj. Themis Bio.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
356.00
-206.00
-57.87%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
356.00
-206.00
-57.87%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
3.00
-4.00
-133.33%
Raw Materials Consumed
25.00
199.00
-174.00
-87.44%
Power & Fuel Cost
26.00
0.00
26.00
0%
Employee Cost
11.00
18.00
-7.00
-38.89%
Operating Expenses
8.00
8.00
0.00
0.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
10.00
-10.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
9.00
-5.00
-55.56%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
81.00
264.00
-183.00
-69.32%
Operating Profit (PBDIT) excl Other Income
69.00
91.00
-22.00
-24.18%
Other Income
1.00
41.00
-40.00
-97.56%
Operating Profit (PBDIT)
71.00
133.00
-62.00
-46.62%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
70.00
132.00
-62.00
-46.97%
Depreciation
5.00
2.00
3.00
150.00%
Profit Before Taxation & Exceptional Items
65.00
130.00
-65.00
-50.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
65.00
130.00
-65.00
-50.00%
Provision for Tax
16.00
29.00
-13.00
-44.83%
Profit After Tax
48.00
100.00
-52.00
-52.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
191.00
728.00
-537.00
-73.76%
Profit Available for appropriations
240.00
829.00
-589.00
-71.05%
Appropriations
240.00
829.00
-589.00
-71.05%
Equity Dividend (%)
67%
500%
-433.00
Earnings Per Share
4.48
40.87
-36.39
-89.04%
Profit And Loss - Net Sales
Net Sales 150.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 69.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

Profit And Loss - Interest
Interest 0.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 48.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024